Evidence map›Paper›PMID 34831077›Full record

ArticleCells2021

Inflammatory Modulation of Polyethylene Glycol-AuNP for Regulation of the Neural Differentiation Capacity of Mesenchymal Stem Cells.

Huey-Shan Hung, Wei-Chien Kao, Chiung-Chyi Shen, Kai-Bo Chang, Cheng-Ming Tang, Meng-Yin Yang, Yi-Chin Yang, Chun-An Yeh, Jia-Jhan Li, Hsien-Hsu Hsieh

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Huey-Shan HungGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Wei-Chien KaoGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Chiung-Chyi ShenDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Kai-Bo ChangGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Cheng-Ming TangCollege of Oral Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-2103-6670
Meng-Yin YangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Yi-Chin YangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.ORCID 0000-0002-9651-3761
Chun-An YehGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Jia-Jhan LiGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Hsien-Hsu HsiehBlood Bank, Taichung Veterans General Hospital, Taichung 407204, Taiwan.ORCID 0000-0003-4985-7446
China Medical University · TWTaichung Veterans General Hospital · TW

Funding

Ministry of Science and Technology, Taiwan 110-2314-B-039-049
6 · The paper itself

Abstract

A nanocomposite composed of polyethylene glycol (PEG) incorporated with various concentrations (~17.4, ~43.5, ~174 ppm) of gold nanoparticles (Au) was created to investigate its biocompatibility and biological performance in vitro and in vivo. First, surface topography and chemical composition was determined through UV-visible spectroscopy (UV-Vis), Fourier-transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), scanning electron microscopy (SEM), free radical scavenging ability, and water contact angle measurement. Additionally, the diameters of the PEG-Au nanocomposites were also evaluated through dynamic light scattering (DLS) assay. According to the results, PEG containing 43.5 ppm of Au demonstrated superior biocompatibility and biological properties for mesenchymal stem cells (MSCs), as well as superior osteogenic differentiation, adipocyte differentiation, and, particularly, neuronal differentiation. Indeed, PEG-Au 43.5 ppm induced better cell adhesion, proliferation and migration in MSCs. The higher expression of the SDF-1α/CXCR4 axis may be associated with MMPs activation and may have also promoted the differentiation capacity of MSCs. Moreover, it also prevented MSCs from apoptosis and inhibited macrophage and platelet activation, as well as reactive oxygen species (ROS) generation. Furthermore, the anti-inflammatory, biocompatibility, and endothelialization capacity of PEG-Au was measured in a rat model. After implanting the nanocomposites into rats subcutaneously for 4 weeks, PEG-Au 43.5 ppm was able to enhance the anti-immune response through inhibiting CD86 expression (M1 polarization), while also reducing leukocyte infiltration (CD45). Moreover, PEG-Au 43.5 ppm facilitated CD31 expression and anti-fibrosis ability. Above all, the PEG-Au nanocomposite was evidenced to strengthen the differentiation of MSCs into various cells, including fat, vessel, and bone tissue and, particularly, nerve cells. This research has elucidated that PEG combined with the appropriate amount of Au nanoparticles could become a potential biomaterial able to cooperate with MSCs for tissue regeneration engineering.

Indexed as

Cell DifferentiationAnimalsAnti-Inflammatory AgentsApoptosisBiocompatible MaterialsCell CycleCell MovementCells, CulturedChemokine CXCL12GoldHumansInflammationMesenchymal Stem CellsMetal NanoparticlesNeuronsPolyethylene GlycolsAnti-Inflammatory AgentsBiocompatible MaterialsChemokine CXCL12CXCR4 protein, humanGoldPolyethylene GlycolsReceptors, CXCR4differentiationgold nanoparticlesmesenchymal stem cellspolyethylene glycoltissue regeneration

Identifiers

PMID34831077
PMCPMC8616252
OpenAlexW3210966630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.